ACH
Accendra Health, Inc. NYSE Listed Mar 17, 1980$3.73
Mkt Cap $285.5M
52w Low $1.84
24.6% of range
52w High $9.55
50d MA $2.76
200d MA $3.70
P/E (TTM)
-0.3x
EV/EBITDA
9.0x
P/B
—
Debt/Equity
-4.8x
ROE
238.8%
P/FCF
-0.7x
RSI (14)
—
ATR (14)
—
Beta
1.26
50d MA
$2.76
200d MA
$3.70
Avg Volume
863.7K
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
10900 Nuckols Road · Glen Allen, VA 23060 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | AMC | 0.22 | 0.21 | -4.5% | 2.48 | -12.1% | +5.2% | +4.8% | +7.3% | +4.8% | -2.4% | — |
| Oct 30, 2025 | AMC | 0.23 | 0.25 | +8.7% | 4.96 | +0.4% | -20.0% | -30.4% | -29.6% | -32.5% | -37.1% | — |
| Aug 11, 2025 | AMC | 0.27 | 0.26 | -3.7% | 4.63 | +0.4% | +18.1% | +15.1% | +16.6% | +22.7% | +17.7% | — |
| May 8, 2025 | AMC | 0.20 | 0.23 | +15.0% | 6.99 | +0.9% | +0.3% | +2.3% | +3.4% | +0.1% | +1.4% | — |
| Feb 28, 2025 | AMC | 0.53 | 0.55 | +3.8% | 9.58 | -1.9% | -2.7% | +1.4% | +1.7% | +4.1% | +4.4% | — |
| Nov 4, 2024 | AMC | 0.40 | 0.42 | +5.0% | 12.00 | -1.5% | -1.7% | +13.4% | +6.3% | +7.5% | +11.4% | — |
| Aug 2, 2024 | AMC | 0.33 | 0.36 | +9.1% | 16.20 | -5.7% | -8.2% | -4.9% | -8.5% | -5.5% | -6.4% | — |
| May 3, 2024 | AMC | 0.17 | 0.19 | +11.8% | 18.21 | +0.2% | +5.5% | +3.8% | -0.5% | +0.9% | +2.3% | — |
| Feb 20, 2024 | AMC | 0.68 | 0.69 | +1.5% | 21.54 | +0.2% | +1.2% | +7.7% | +10.9% | +9.9% | +15.0% | — |
| Nov 3, 2023 | AMC | 0.36 | 0.44 | +22.2% | 19.71 | -2.6% | -1.7% | +0.2% | -6.2% | -10.6% | -12.6% | — |
| Aug 4, 2023 | AMC | 0.16 | 0.18 | +12.5% | 19.02 | -2.4% | +1.2% | -0.8% | +7.0% | +6.2% | +6.1% | — |
| May 5, 2023 | AMC | -0.09 | 0.05 | +155.6% | 18.63 | +3.2% | -4.6% | -5.6% | -1.3% | -0.1% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.48 | $2.18 | -12.1% | +5.2% | +4.8% | +7.3% | +4.8% | -2.4% |
| Jan 9 | Citigroup | Maintains | Buy → Buy | — | $2.36 | $2.36 | +0.0% | +4.2% | +13.6% | +6.4% | +9.3% | +7.2% |
| Nov 3 | UBS | Downgrade | Buy → Neutral | — | $3.97 | $3.83 | -3.5% | -13.1% | -12.1% | -15.6% | -21.4% | -19.9% |
| Aug 27 | JP Morgan | Maintains | Underweight → Underweight | — | $5.01 | $5.00 | -0.2% | -2.4% | -1.0% | -2.2% | +6.4% | +9.4% |
| Aug 13 | UBS | Maintains | Buy → Buy | — | $5.47 | $5.57 | +1.8% | -2.6% | -1.3% | +3.8% | -0.4% | -2.0% |
| Aug 12 | BofA Securities | Maintains | Underperform → Underperform | — | $4.63 | $4.65 | +0.4% | +18.1% | +15.1% | +16.6% | +22.7% | +17.7% |
| Aug 12 | Citigroup | Maintains | Buy → Buy | — | $4.63 | $4.65 | +0.4% | +18.1% | +15.1% | +16.6% | +22.7% | +17.7% |
| Aug 12 | Baird | Maintains | Outperform → Outperform | — | $4.63 | $4.65 | +0.4% | +18.1% | +15.1% | +16.6% | +22.7% | +17.7% |
| Aug 7 | Credit Suisse | Maintains | Neutral → Neutral | — | $19.02 | $18.57 | -2.4% | +1.2% | -0.8% | +7.0% | +6.2% | +6.1% |
| May 7 | Citigroup | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| May 7 | UBS | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 7 | Credit Suisse | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| May 7 | Baird | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Mar 7 | Citigroup | Maintains | Neutral → Neutral | — | $15.51 | $15.44 | -0.5% | -6.5% | -5.7% | -9.9% | -14.1% | -13.2% |
| Mar 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $16.90 | $16.90 | +0.0% | -8.2% | -14.2% | -13.5% | -17.3% | -21.1% |
| Feb 28 | Baird | Maintains | Neutral → Neutral | — | $19.61 | $16.60 | -15.3% | -21.8% | -21.3% | -16.4% | -13.8% | -20.9% |
| Nov 2 | Citigroup | Maintains | Neutral → Neutral | — | $17.55 | $17.68 | +0.7% | +4.9% | +3.9% | +9.1% | +9.2% | +8.1% |
| Oct 13 | Credit Suisse | Maintains | Neutral → Neutral | — | $15.10 | $14.36 | -4.9% | +1.8% | +1.9% | +9.4% | +10.4% | +7.4% |
| Oct 12 | Citigroup | Downgrade | Buy → Neutral | — | $23.22 | $18.48 | -20.4% | -35.0% | -33.8% | -33.7% | -28.9% | -28.2% |
| Oct 11 | Baird | Downgrade | Outperform → Neutral | — | $23.04 | $23.04 | +0.0% | +0.8% | -34.5% | -33.3% | -33.2% | -28.3% |
| Aug 3 | Baird | Maintains | Outperform → Outperform | — | $36.64 | $33.00 | -9.9% | -11.5% | -10.8% | -10.7% | -6.7% | -9.2% |
| Aug 3 | Credit Suisse | Maintains | Neutral → Neutral | — | $36.64 | $33.00 | -9.9% | -11.5% | -10.8% | -10.7% | -6.7% | -9.2% |
| Feb 27 | Credit Suisse | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Aug 3 | Credit Suisse | Maintains | Neutral → Neutral | — | $46.90 | $42.45 | -9.5% | -8.8% | -16.8% | -17.3% | -16.8% | -17.4% |
| May 26 | Credit Suisse | Maintains | Neutral → Neutral | — | $32.40 | $33.89 | +4.6% | +36.2% | +39.4% | +38.0% | +31.7% | +30.8% |
| May 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $34.31 | $34.10 | -0.6% | -2.6% | -1.8% | -6.0% | -8.5% | -7.2% |
| Nov 4 | UBS | Maintains | Neutral → Neutral | — | $25.45 | $25.83 | +1.5% | -6.3% | -0.4% | -3.7% | -11.6% | -12.9% |
| Sep 24 | Barclays | Upgrade | Underweight → Equal Weight | — | $13.79 | $19.19 | +39.2% | +47.3% | +47.6% | +57.3% | +70.6% | +82.1% |
| Sep 24 | Credit Suisse | Maintains | Neutral → Neutral | — | $13.79 | $19.19 | +39.2% | +47.3% | +47.6% | +57.3% | +70.6% | +82.1% |
| Aug 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $14.25 | $13.97 | -2.0% | -7.3% | -10.5% | -3.4% | +4.0% | +13.3% |
| Jul 21 | Barclays | Maintains | Underweight → Underweight | — | $7.94 | $10.24 | +29.0% | +81.4% | +62.1% | +87.8% | +88.9% | +96.0% |
| Jun 9 | CFRA | Maintains | Buy → Buy | — | $9.12 | $9.03 | -1.0% | -6.7% | -13.8% | -20.0% | -20.1% | -18.0% |
| May 6 | CFRA | Maintains | Buy → Buy | — | $7.47 | $7.24 | -3.1% | -12.6% | -6.3% | -9.6% | -2.9% | -10.2% |
| May 4 | Baird | Downgrade | Outperform → Neutral | — | $7.36 | $7.40 | +0.5% | +9.1% | +1.5% | -11.3% | -4.9% | -8.3% |
| Mar 29 | CFRA | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Jan 20 | Baird | Upgrade | Neutral → Outperform | — | — | — | — | — | — | — | — | — |
| Jan 17 | UBS | Maintains | Neutral → Neutral | — | $7.63 | $7.55 | -1.0% | -3.9% | -4.7% | +1.2% | -2.8% | -1.6% |
| Jan 3 | Bank of America | Maintains | Neutral → Neutral | — | $6.51 | $6.50 | -0.2% | -0.6% | -0.2% | +0.0% | -2.8% | +8.1% |
| Jan 2 | BofA Securities | Maintains | Neutral → Neutral | — | $6.33 | $6.25 | -1.3% | +2.8% | +2.2% | +2.7% | +2.8% | +0.0% |
| Oct 31 | Barclays | Maintains | Underweight → Underweight | — | $14.20 | $10.74 | -24.4% | -44.4% | -37.6% | -33.7% | -33.9% | -34.6% |
| Mar 8 | Barclays | Maintains | Underweight → Underweight | — | $17.11 | $17.08 | -0.2% | -1.8% | -0.5% | +1.4% | +0.3% | -2.4% |
| Feb 14 | JP Morgan | Maintains | Underweight → Underweight | — | $14.94 | $15.25 | +2.1% | +2.6% | +4.4% | +7.6% | +3.1% | +6.4% |
| Dec 18 | JP Morgan | Downgrade | Neutral → Underweight | — | $19.05 | $19.08 | +0.2% | -1.6% | +1.8% | +2.1% | +1.7% | -0.7% |
| Nov 19 | Credit Suisse | Maintains | Underperform → Underperform | — | — | — | — | — | — | — | — | — |
| Nov 1 | Leerink Swann | Maintains | Market Perform → Market Perform | — | $24.57 | $24.43 | -0.6% | -14.7% | -24.0% | -20.5% | -21.2% | -22.4% |
| Aug 31 | Baird | Upgrade | Underperform → Neutral | — | $27.74 | $27.89 | +0.5% | +0.7% | +2.1% | +1.3% | +2.7% | +2.1% |
| Nov 7 | Bank of America | Downgrade | Neutral → Underperform | — | $32.63 | $32.44 | -0.6% | -2.1% | -1.8% | -2.1% | -1.0% | +0.3% |
| Nov 6 | BofA Securities | Downgrade | Neutral → Underperform | — | — | — | — | — | — | — | — | — |
| Oct 6 | UBS | Maintains | Sell → Sell | — | $33.68 | $33.23 | -1.3% | +0.4% | +0.4% | +1.5% | -0.7% | -0.5% |
| Apr 20 | Baird | Downgrade | Neutral → Underperform | — | $41.20 | $38.34 | -6.9% | -9.0% | -11.5% | -10.3% | -10.0% | -9.6% |
No insider trades available.
Data updated apr 24, 2026 10:30am
· Source: massive.com